{"schema_version":"secwatch.filing_event.v1","accession":"0001759425-25-000034","form_type":"8-K","ticker":"MIRM","cik":"0001759425","company_name":"Mirum Pharmaceuticals, Inc.","filed_at":"2025-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.613233+00:00","generated_at":"2026-05-20T04:35:27.809838+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Mirum Pharmaceuticals 2025 Annual Meeting results: three directors elected","bullets":["Class III directors elected: Laura Brege (17.97M for, 18.17M withheld), Michael Grey (30.78M for), Christopher Peetz (35.98M for).","Ratified Ernst & Young as independent auditor for FY2025: 43.12M for, 19.2K against, 19.4K abstentions.","Advisory vote on executive compensation approved: 34.67M for, 1.46M against, 8.9K abstentions.","Broker non-votes of 7.02M on director elections and compensation proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001759425-25-000034","json":"https://secwatch.observer/filing/0001759425-25-000034.json","markdown":"https://secwatch.observer/filing/0001759425-25-000034.md","text":"https://secwatch.observer/filing/0001759425-25-000034.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759425/000175942525000034/0001759425-25-000034-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759425/000175942525000034/mirm-20250529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T04:35:27.809838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}